These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8301099)

  • 1. Pharmacological study of SR 47436, a non-peptide angiotensin II AT1-receptor antagonist, in conscious monkeys.
    Lacour C; Roccon A; Cazaubon C; Segondy D; Nisato D
    J Hypertens; 1993 Nov; 11(11):1187-94. PubMed ID: 8301099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pharmacodynamic study of SR 47436, a selective AT1 receptor antagonist, on blood pressure in conscious cynomolgus monkeys.
    Roccon A; Marchionni D; Donat F; Segondy D; Cazaubon C; Nisato D
    Br J Pharmacol; 1994 Jan; 111(1):145-50. PubMed ID: 8012690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II receptor subtypes in renal cortex of rats and rhesus monkeys.
    Gibson RE; Thorpe HH; Cartwright ME; Frank JD; Schorn TW; Bunting PB; Siegl PK
    Am J Physiol; 1991 Sep; 261(3 Pt 2):F512-8. PubMed ID: 1653532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of SR 47436 (BMS-186295), a non-peptide angiotensin AT1 receptor antagonist in hypertensive rat models.
    Lacour C; Canals F; Galindo G; Cazaubon C; Segondy D; Nisato D
    Eur J Pharmacol; 1994 Nov; 264(3):307-16. PubMed ID: 7698170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
    Siegl PK; Chang RS; Mantlo NB; Chakravarty PK; Ondeyka DL; Greenlee WJ; Patchett AA; Sweet CS; Lotti VJ
    J Pharmacol Exp Ther; 1992 Jul; 262(1):139-44. PubMed ID: 1625193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac haemodynamic effects of the non-peptide, angiotensin II-receptor antagonist, DuP 753, in conscious Long Evans and Brattleboro rats.
    Batin P; Gardiner SM; Compton AM; Kemp PA; Bennett T
    Br J Pharmacol; 1991 Jun; 103(2):1585-91. PubMed ID: 1884112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal and cardiovascular effects of losartan (DuP753), an angiotensin receptor antagonist, in nonhuman primates.
    DeGraaf GL; Pals DT; Couch SJ; Lawson JA
    J Pharmacol Exp Ther; 1993 Jan; 264(1):6-10. PubMed ID: 8423551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartan.
    Goldberg MR; Lo MW; Christ DD; Chiou R; Furtek CI; Amit O; Carides A; Biollaz J; Piguet V; Nussberger J; Brunner HR
    Clin Pharmacol Ther; 1997 Jan; 61(1):59-69. PubMed ID: 9024174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
    Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
    J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal effects of angiotensin I-receptor blockade and angiotensin convertase inhibition in man.
    Schmitt F; Natov S; Martinez F; Lacour B; Hannedouche TP
    Clin Sci (Lond); 1996 Mar; 90(3):205-13. PubMed ID: 8777826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype.
    Criscione L; de Gasparo M; Bühlmayer P; Whitebread S; Ramjoué HP; Wood J
    Br J Pharmacol; 1993 Oct; 110(2):761-71. PubMed ID: 8242249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between inhibition of renal angiotensin II production and hemodynamic effect of captopril in anesthetized rabbit.
    Li T; Zimmerman BG
    J Hypertens; 1992 Aug; 10(8):795-805. PubMed ID: 1325512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism.
    Ohlstein EH; Gellai M; Brooks DP; Vickery L; Jugus J; Sulpizio A; Ruffolo RR; Weinstock J; Edwards RM
    J Pharmacol Exp Ther; 1992 Aug; 262(2):595-601. PubMed ID: 1501114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Juxtaglomerular cell hypertrophy and hyperplasia induced in rhesus monkeys by angiotensin II receptor antagonists.
    Owen RA; Molon-Noblot S; Hubert MF; Siegl PK; Eydelloth RS; Keenan KP
    Lab Invest; 1994 Oct; 71(4):543-51. PubMed ID: 7967510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of SR 47436, a new nonpeptide AT1 subtype angiotensin II receptor antagonist.
    Cazaubon C; Gougat J; Bousquet F; Guiraudou P; Gayraud R; Lacour C; Roccon A; Galindo G; Barthelemy G; Gautret B
    J Pharmacol Exp Ther; 1993 May; 265(2):826-34. PubMed ID: 8496828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonpeptide angiotensin II receptor antagonists. Studies with DuP 753 and EXP3174 in dogs.
    Wong PC; Hart SD; Duncia JV; Timmermans PB
    Eur J Pharmacol; 1991 Sep; 202(3):323-30. PubMed ID: 1748155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta adrenoceptor blockade in rabbit inhibits the renin-releasing effect of AT1 receptor antagonist losartan.
    Hajj-Ali AF; Wong PC
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1423-7. PubMed ID: 7903389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive effects of losartan and enalapril on blood pressure and plasma active renin.
    Azizi M; Guyene TT; Chatellier G; Wargon M; Ménard J
    Hypertension; 1997 Feb; 29(2):634-40. PubMed ID: 9040450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the angiotensin II receptor antagonist Losartan (DuP 753/MK 954) on arterial blood pressure, heart rate, plasma concentrations of angiotensin II and renin and the pressor response to infused angiotensin II in the salt-deplete dog.
    MacFadyen RJ; Tree M; Lever AF; Reid JL
    Clin Sci (Lond); 1992 Nov; 83(5):549-56. PubMed ID: 1335390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal differences between the involvement of angiotensin II and endothelin in the cardiovascular responses to endotoxaemia in conscious rats.
    Gardiner SM; Kemp PA; March JE; Bennett T
    Br J Pharmacol; 1996 Dec; 119(8):1619-27. PubMed ID: 8982510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.